BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 31802860)

  • 1. Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To
    Montón C; Prina E; Pomares X; Cugat JR; Casabella A; Oliva JC; Gallego M; Monsó E
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2365-2373. PubMed ID: 31802860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of treatment with nebulized colistin in patients with COPD.
    Bruguera-Avila N; Marin A; Garcia-Olive I; Radua J; Prat C; Gil M; Ruiz-Manzano J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2909-2915. PubMed ID: 29042767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection].
    Tabernero Huguet E; Gil Alaña P; Alkiza Basañez R; Hernández Gil A; Garros Garay J; Artola Igarza JL
    Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiological Progress in Patients with Bronchial Infection with Pseudomonas aeruginosa Treated with Nebulised Colistin.
    Bruguera-Àvila N; Garcia-Olive I; Marin A; Prat C; Lacoma A; Gil M; Abad Capa J
    Respiration; 2019; 97(6):501-507. PubMed ID: 30605912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with nebulised colistin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa].
    López-Gil Otero MM; Romero-Ventosa EY; Feijoo-Meléndez D; Casanova-Martínez C; Otero-Millán L; Piñeiro-Corrales G
    Rev Esp Quimioter; 2019 Jun; 32(3):217-223. PubMed ID: 30924621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
    Greenwood J; Schwarz C; Sommerwerck U; Nash EF; Tamm M; Cao W; Mastoridis P; Debonnett L; Hamed K
    Ther Adv Respir Dis; 2017 Jul; 11(7):249-260. PubMed ID: 28614995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Safety Outcomes of Long-Term Azithromycin Therapy in Severe COPD Beyond the First Year of Treatment.
    Pomares X; Montón C; Bullich M; Cuevas O; Oliva JC; Gallego M; Monsó E
    Chest; 2018 May; 153(5):1125-1133. PubMed ID: 29427576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
    Al-Aloul M; Nazareth D; Walshaw M
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease.
    Naderi N; Assayag D; Mostafavi-Pour-Manshadi SM; Kaddaha Z; Joubert A; Ouellet I; Drouin I; Li PZ; Bourbeau J
    Respir Med; 2018 May; 138():129-136. PubMed ID: 29724384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations.
    Pomares X; Montón C; Espasa M; Casabon J; Monsó E; Gallego M
    Int J Chron Obstruct Pulmon Dis; 2011; 6():449-56. PubMed ID: 22003290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.
    Uzun S; Djamin RS; Kluytmans J; Van't Veer NE; Ermens AA; Pelle AJ; Mulder P; van der Eerden MM; Aerts J
    Trials; 2012 Jun; 13():82. PubMed ID: 22682323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of
    Blanco-Aparicio M; Saleta Canosa JL; Valiño López P; Martín Egaña MT; Vidal García I; Montero Martínez C
    Chron Respir Dis; 2019; 16():1479973119872513. PubMed ID: 31480862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study.
    Planquette B; Péron J; Dubuisson E; Roujansky A; Laurent V; Le Monnier A; Legriel S; Ferre A; Bruneel F; Chiles PG; Bedos JP
    Int J Chron Obstruct Pulmon Dis; 2015; 10():379-88. PubMed ID: 25733827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis.
    Steinfort DP; Steinfort C
    Intern Med J; 2007 Jul; 37(7):495-8. PubMed ID: 17547727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.
    Montero M; Horcajada JP; Sorlí L; Alvarez-Lerma F; Grau S; Riu M; Sala M; Knobel H
    Infection; 2009 Oct; 37(5):461-5. PubMed ID: 19499183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced tolerance to nebulized colistin after severe reaction to the drug.
    Domínguez-Ortega J; Manteiga E; Abad-Schilling C; Juretzcke MA; Sánchez-Rubio J; Kindelan C
    J Investig Allergol Clin Immunol; 2007; 17(1):59-61. PubMed ID: 17323867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
    Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
    Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis.
    Stockmann C; Hillyard B; Ampofo K; Spigarelli MG; Sherwin CM
    Expert Rev Respir Med; 2015 Feb; 9(1):13-22. PubMed ID: 25417708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific IgA against
    Millares L; Martí S; Ardanuy C; Liñares J; Santos S; Dorca J; García-Nuñez M; Quero S; Monsó E
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2807-2811. PubMed ID: 29033561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.